Literature DB >> 34195809

Classification performance of clinical risk scoring in suspected acute coronary syndrome beyond a rule-out troponin profile.

Ehsan Khan1,2, Kristina Lambrakis1,2, Andrew Blyth1,2, Anil Seshadri1,2, Michael J R Edmonds2, Tom Briffa3, Louise A Cullen4,5,6, Stephen Quinn7,8, Matthew Horsfall1,2, Erin Morton1, John K French9, Cynthia Papendick3, Adam J Nelson2,10,11, Derek P Chew1,2,3.   

Abstract

AIMS: High-sensitivity cardiac troponin strategies can provide risk stratification in patients with suspected acute coronary syndrome (ACS) in the emergency department (ED). This study evaluated whether clinical risk scoring improves the classification performance of a rule-out profile in suspected ACS. METHODS AND
RESULTS: Patients presenting to ED with suspected ACS as part of the RAPID-TnT trial randomized to the intervention arm were included. Results ≥5 ng/L were available for all participants in this analysis. We evaluated the Thrombolysis In Myocardial Infarction (TIMI) risk score, History ECG Age Risk factors Troponin (HEART) score, and Emergency Department Assessment of Chest pain Score (EDACS) in addition to a rule-out profile based on the 0/1-h high-sensitivity cardiac troponin T protocol (<5 ng/L or ≤12 ng/L and a change of <3 ng/L at 1-h) using test performance parameters focusing on low-risk groups to identify the primary endpoint (TIMI ≤ 1, HEART ≤ 3, EDACS < 16). Primary endpoint was a composite of type 1/2 myocardial infarction (MI) at index presentation and all-cause mortality or type 1/2 MI at 30 days. A total of 3378 participants were enrolled between August 2015 and April 2019 of which 108 were ineligible/withdrew consent (intervention arm: n = 1638). Sensitivity, specificity, negative predictive value (NPV), and area under the curve (AUC) of the rule-out profile was 94.4%, 76.8%, 99.6%, and 0.86, respectively with 72.9% identified as 'low-risk'. Adding the clinical risk scores did not improve the sensitivity, NPV, or AUC with significantly lower specificity and 'low-risk' classified participants.
CONCLUSIONS: Addition of clinical risk scores to rule-out profile did not demonstrate improved classification performance for identifying the composite of type 1/2 MI at index presentation and all-cause mortality or type 1/2 MI at 30 days. CLINICAL TRIALS REGISTRATION: URL: https://www.anzctr.org.au. Reg. No. ACTRN12615001379505. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Acute coronary syndromes; Chest pain assessment; Clinical trial; Myocardial infarction; Risk prediction; Troponin

Mesh:

Substances:

Year:  2021        PMID: 34195809     DOI: 10.1093/ehjacc/zuab040

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  2 in total

1.  Development and validation of a comprehensive early risk prediction model for patients with undifferentiated acute chest pain.

Authors:  Luke P Dawson; Emily Andrew; Ziad Nehme; Jason Bloom; Danny Liew; Shelley Cox; David Anderson; Michael Stephenson; Jeffrey Lefkovits; Andrew J Taylor; David Kaye; Louise Cullen; Karen Smith; Dion Stub
Journal:  Int J Cardiol Heart Vasc       Date:  2022-04-28

2.  Association of Chest Pain Protocol-Discordant Discharge With Outcomes Among Emergency Department Patients With Modest Elevations of High-Sensitivity Troponin.

Authors:  Ayesha Khan; Muhammad S Saleem; Keith D Willner; Luke Sullivan; Elsie Yu; Osama Mahmoud; Amro Alsaid; Martin E Matsumura
Journal:  JAMA Netw Open       Date:  2022-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.